Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

Talaris Therapeutics appoints current CFO Mary Kay as interim CEO

May 26, 2023 7:32 AM ETTalaris Therapeutics, Inc. (TALS)By: Deepa Sarvaiya, SA News Editor
  • Talaris Therapeutics (NASDAQ:TALS) put its CFO in charge on Friday, replacing a CEO Scott Requadt, who will be leaving the Company as part of a planned workforce reduction, as previously announced by the Company.
  • CFO Mary Kay Fenton has been named interim CEO with immediate effect.
  • The company is currently conducting a comprehensive review of strategic alternatives focused on maximizing shareholder value, including possible business combinations and/or a divestiture of the Company’s cell therapy CMC capabilities. Source: Press Release

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.